Skip to content
OpenCapital
Get started

Iovance Biotherapeutics, Inc. IOVA EPS (Diluted)

EPS (Diluted) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.31+9.2%
Gilead Sciences logo
Gilead SciencesGILD
$1.61+54.8%
Immunome logo
ImmunomeIMNM
-$0.48+7.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.62-313%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$0.73-15.9%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$1.15-5.5%

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.98B+32.4%
Enterprise value$1.83B+33.2%
P/S6.9×-0.1×

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s EPS (diluted)?
Iovance Biotherapeutics, Inc. (IOVA) reported EPS (diluted) of -$0.19 in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s EPS (diluted) changed year-over-year?
Iovance Biotherapeutics, Inc.'s EPS (diluted) increased by 47.2% year-over-year, from -$0.36 to -$0.19.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s EPS (diluted)?
Over 3 years (2021 to 2024), Iovance Biotherapeutics, Inc.'s EPS (diluted) has grown at a -16.6% compound annual growth rate (CAGR), from -$2.22 to -$1.29.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.